MétaCan
Menu
Back to cohort
Record W4308843454 · doi:10.26685/urncst.409

Comparing Metformin, Inositol, and Lifestyle Modifications to Improve Symptomatology of Polycystic Ovary Syndrome (PCOS): A Research Protocol

2022· article· en· W4308843454 on OpenAlexaff
Jasmine Dhaliwal

Bibliographic record

VenueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2022
Typearticle
Languageen
FieldMedicine
TopicOvarian function and disorders
Canadian institutionsMcMaster University
Fundersnot available
KeywordsPolycystic ovaryMetforminInsulin resistanceHyperandrogenismAnovulationMedicineHyperinsulinemiaEndocrinologyInternal medicineInfertilityGynecologyMetabolic syndromeOvulationObesityInsulinPhysiologyHormoneBiologyPregnancy

Abstract

fetched live from OpenAlex

Introduction: Polycystic ovary syndrome (PCOS), a common endocrinological disorder of women of reproductive age, affects about 5-20% of women globally. It is diagnosed through the Rotterdam criteria with the presence of two out of three clinical features of oligo-anovulation, hyperandrogenism, and/or polycystic ovaries. Hyperinsulinemia and insulin resistance are central features of PCOS , along with obesity. This study aims to compare three treatment interventions: metformin, inositol, and lifestyle modifications to improve symptoms of PCOS. Methods: In this four-arm randomized study, 48 women of reproductive age (25-36 years) will be recruited over a 12-week period. Impacts of treatment types (metformin, inositol and lifestyle modifications) will be determined in improving symptoms of PCOS. Control group, “Group A” (N=12) will not be going through any treatment; “Group B” (N=12) will be taking 500 mg of metformin daily, with close assessment of side effects; “Group C” will take 2 g of inositol supplements twice daily with a 40:1 myo-inositol and D-chiro-inositol ratio; and “Group D” will undergo lifestyle modifications, closely monitored by personal trainers, nutritionists, and dietitians, to facilitate weight loss. ANOVA, Pearson’s correlation, and Kruskal-Wallis H test will be conducted to determine significance. Anticipated Results: PCOS patients of group C, inositol intake, may be seen to have greatest improvements in PCOS symptomatology due to its insulin sensitizing, metabolic, and hormonal influences, with minimal adverse effects. Discussion: Previous studies have shown inositol consumption to result in significant improvements in insulin resistance, menstrual cycle regularity, Acne score, Ferriman-Gallwey score, endocrine and metabolic parameters, reduced serum levels of total testosterone, and elevated sex hormone binding globulin in women with PCOS. Metformin may yield similar effects to inositol, but greater adverse effects may be present. Through a reduced BMI, lifestyle modifications have shown to significantly reduce total androgen profile, waist circumference, and lipid profile while increasing clinical pregnancy rate by 20%. Conclusion: The comparison of three treatment modalities may be beneficial for PCOS patients to provide optimal treatment. It may be beneficial to compare a combination of treatment interventions in the future for additive or synergistic effects.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Protocol · Consensus signal: Protocol
Teacher disagreement score0.037
Threshold uncertainty score0.123

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.010
Meta-epidemiology (narrow)0.0040.002
Meta-epidemiology (broad)0.0080.005
Bibliometrics0.0020.002
Science and technology studies0.0030.002
Scholarly communication0.0020.002
Open science0.0030.002
Research integrity0.0050.005
Insufficient payload (model declined to judge)0.0370.005

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.090
GPT teacher head0.447
Teacher spread0.357 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreProtocol

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueUndergraduate Research in Natural and Clinical Science and Technology (URNCST) JournalSame topicOvarian function and disordersFrench-language works237,207